The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1521
Prescription Drug Prices in the US
The full article is available to subscribers Subscriber Login   

Per capita spending on prescription drugs in the US is higher than in other industrialized nations, including Canada.1

OTHER COUNTRIES — In most industrialized countries, unlike the US, drug prices are regulated by the government. Centralized advisory boards determine the clinical efficacy and cost-effectiveness of a drug. Prices are based in part on external price referencing (comparison of drug prices in several countries to determine a reference price) and are often transparent and capped.2 Fewer payers are involved, and in some countries, there is only a single public payer.

LIST PRICE vs NEGOTIATED PRICE — Drug pricing in the US is complicated by multiple factors, including list prices that do not reflect what is actually paid for a drug, the number of middlemen involved in getting a drug from the manufacturer to ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Prescription Drug Prices in the US
Article code: 1521a
 Electronic, downloadable article - $25